Singular Genomics Systems, Inc.
Singular Genomics Systems, Inc., a pioneering force in the genomics industry, is headquartered in the United States. Founded in 2016, the company has rapidly established itself as a leader in next-generation sequencing (NGS) technology, focusing on innovative solutions for genomic research and clinical applications. With a commitment to advancing precision medicine, Singular Genomics offers unique products such as the G4 sequencer, designed to deliver high-throughput, cost-effective sequencing capabilities. This cutting-edge technology sets the company apart by enabling researchers to conduct complex genomic analyses with unprecedented speed and accuracy. Recognised for its significant contributions to the field, Singular Genomics continues to expand its operational reach, positioning itself as a key player in the global genomics landscape.
DitchCarbon Score
How does Singular Genomics Systems, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Singular Genomics Systems, Inc.'s score of 18 is higher than 66% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Singular Genomics Systems, Inc.'s reported carbon emissions
Singular Genomics Systems, Inc., headquartered in the US, currently does not have publicly available carbon emissions data or specific reduction targets. As such, there are no reported figures for their Scope 1, 2, or 3 emissions. The company has not outlined any formal climate commitments or initiatives aimed at reducing carbon emissions. In the absence of specific data, it is unclear how Singular Genomics is addressing climate change or contributing to sustainability efforts within the biotechnology sector.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Singular Genomics Systems, Inc. is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
